Navigation Links
Mylan Granted Temporary Restraining Order Against GlaxoSmithKline and Apotex Prohibiting the Supply, Sale and/or Importing of a Generic Version of Paxil CR
Date:9/21/2010

PITTSBURGH, Sept. 21 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today obtained a temporary restraining order from the U.S. District Court for the District of New Jersey that prohibits Apotex from "using, offering to sell, selling or shipping or otherwise launching … or importing" all three strengths of a generic version of GlaxoSmithKline's Paxil CR, Paroxetine Hydrochloride (HCl) Extended-release (ER) Tablets, 12.5 mg, 25 mg and 37.5 mg. The order also prohibits GlaxoSmithKline from supplying Apotex with a generic version of the product. The order was entered today, and the court has scheduled further hearings on the matter for Oct. 18.

Mylan is currently selling all three strengths of Paroxetine HCl ER.

Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 140 countries and territories. The company maintains one of the industry's broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world's largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies. For more information, please visit www.mylan.com.


'/>"/>
SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Mylan Announces Settlement Agreement Related to Antidepressant Effexor XR(R)
2. Mylan Receives FDA Approval for Generic Version of Parkinsons Treatment Sinemet(R)
3. Mylan Schedules Third Quarter 2009 Financial Results Conference Call and Live Webcast
4. Mylan Receives FDA Approval for Generic Version of Anticonvulsant Topamax(R) Sprinkle Capsules
5. Mylan Confirms First-to-File Patent Challenge Relating to Caduet(R)
6. Mylan Receives Approval for Generic Version of GoLytely(R)
7. Mylan Declares Quarterly Preferred Stock Dividend
8. Mylan Pre-Pays All Scheduled 2011 Term-Loan Borrowings
9. Mylan Confirms First-to-File Patent Challenge Relating to Vytorin(R) Cholesterol Medication
10. Mylans President of Europe, Middle East and Africa Elected President of European Generic Medicines Association
11. Mylan Receives Tentative FDA Approval Under PEPFAR for Matrix Laboratories New Drug Application (NDA) for Efavirenz Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
(Date:7/10/2017)...  BDI Group subsidiary Pathway Purchasing Network, a ... serving specialty pharmacies, home infusion companies and physician ... value-added member programs designed to help organizations gain ... improve access and affordability for patients who rely ... Pathway has worked with ...
(Date:7/6/2017)... -- ThriveRx, the nutrition division of Diplomat Specialty Infusion Group, is celebrating ... support. To celebrate its anniversary, ThriveRx recently launched a redesigned ... look with improved organization to create the best user experience for consumers ... ... "We,ve made several great strides throughout ...
Breaking Medicine Technology:
(Date:7/18/2017)... Sherman Oaks, CA (PRWEB) , ... July 18, 2017 , ... ... and Ph.D. scientist extracted cannabis oils, announced today that at the WORLDZ Summit, taking ... Ryan will be speaking on the therapeutic benefits of medical cannabis for both pediatric ...
(Date:7/18/2017)... ... July 18, 2017 , ... ClinicalTrials.gov and the ... You Need to Consider?, **An FDAnews Webinar**, Aug. 2, 2017 — 1:30 p.m. ... “Final Rule for Clinical Trials Registration and Results Information,” is a head-scratcher. After ...
(Date:7/18/2017)... Indio, California (PRWEB) , ... July 18, 2017 ... ... providers working on a lien basis, partners with the best medical professionals who ... Liens pre-screens and pre-approves each medical professional in their network, ensuring that each ...
(Date:7/18/2017)... ... July 18, 2017 , ... An inventor from Seattle, Wash., has developed ... to clean, scrub and moisturize the back and other hard-to-reach areas of the body. ... movement in my upper body, particularly my shoulders. I found it difficult to reach ...
(Date:7/18/2017)... ... 19, 2017 , ... USHEALTH Group, Inc. has been announced ... prestigious CEO World Awards®. The coveted annual CEO World Awards program encompasses ... case studies, corporate social responsibility, and milestones from every major industry in the ...
Breaking Medicine News(10 mins):